Ultralife (ULBI) Competitors $6.84 +0.15 (+2.24%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$6.84 0.00 (0.00%) As of 10/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ULBI vs. RONI, EAF, FREY, ELVA, NVX, NEOV, STEM, SKYX, GAUZ, and CBATShould you be buying Ultralife stock or one of its competitors? The main competitors of Ultralife include Rice Acquisition Corp. II (RONI), GrafTech International (EAF), FREYR Battery (FREY), Electrovaya (ELVA), NOVONIX (NVX), NeoVolta (NEOV), Stem (STEM), SKYX Platforms (SKYX), Gauzy (GAUZ), and China BAK Battery (CBAT). These companies are all part of the "electrical equipment" industry. Ultralife vs. Its Competitors Rice Acquisition Corp. II GrafTech International FREYR Battery Electrovaya NOVONIX NeoVolta Stem SKYX Platforms Gauzy China BAK Battery Rice Acquisition Corp. II (NYSE:RONI) and Ultralife (NASDAQ:ULBI) are both small-cap electrical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations. Does the media refer more to RONI or ULBI? In the previous week, Ultralife had 1 more articles in the media than Rice Acquisition Corp. II. MarketBeat recorded 2 mentions for Ultralife and 1 mentions for Rice Acquisition Corp. II. Rice Acquisition Corp. II's average media sentiment score of 0.75 beat Ultralife's score of 0.00 indicating that Rice Acquisition Corp. II is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rice Acquisition Corp. II 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ultralife 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, RONI or ULBI? Ultralife has higher revenue and earnings than Rice Acquisition Corp. II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRice Acquisition Corp. IIN/AN/A$4.07MN/AN/AUltralife$178.85M0.64$6.31M$0.1936.00 Which has more volatility and risk, RONI or ULBI? Rice Acquisition Corp. II has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Do institutionals & insiders have more ownership in RONI or ULBI? 22.5% of Rice Acquisition Corp. II shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 20.0% of Rice Acquisition Corp. II shares are owned by insiders. Comparatively, 40.0% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is RONI or ULBI more profitable? Ultralife has a net margin of 1.79% compared to Rice Acquisition Corp. II's net margin of 0.00%. Ultralife's return on equity of 2.68% beat Rice Acquisition Corp. II's return on equity.Company Net Margins Return on Equity Return on Assets Rice Acquisition Corp. IIN/A -17.93% -4.49% Ultralife 1.79%2.68%1.74% Do analysts recommend RONI or ULBI? Ultralife has a consensus target price of $14.00, suggesting a potential upside of 104.68%. Given Ultralife's stronger consensus rating and higher possible upside, analysts clearly believe Ultralife is more favorable than Rice Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rice Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ultralife 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryUltralife beats Rice Acquisition Corp. II on 12 of the 13 factors compared between the two stocks. Get Ultralife News Delivered to You Automatically Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ULBI vs. The Competition Export to ExcelMetricUltralifeELEC IndustryComputer SectorNASDAQ ExchangeMarket Cap$111.35M$5.98B$33.02B$10.54BDividend YieldN/A2.51%3.17%4.71%P/E Ratio36.0026.71496.1927.60Price / Sales0.642.621,906.04201.45Price / Cash9.4323.7437.7361.55Price / Book0.853.057.706.76Net Income$6.31M$177.19M$820.34M$275.88M7 Day Performance0.44%0.87%1.82%2.81%1 Month Performance4.11%2.50%9.23%9.24%1 Year Performance-25.16%25.57%24,029.38%35.42% Ultralife Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ULBIUltralife3.4708 of 5 stars$6.84+2.2%$14.00+104.7%-25.2%$111.35M$178.85M36.00560News CoverageAnalyst ForecastRONIRice Acquisition Corp. IIN/A$3.03-0.7%N/A-49.9%$365.88MN/A0.0024Gap UpHigh Trading VolumeEAFGrafTech International0.6576 of 5 stars$13.16-4.9%$16.25+23.5%+3.2%$357.02M$538.78M-1.601,072News CoverageAnalyst ForecastFREYFREYR Battery1.7108 of 5 stars$2.20-3.1%$4.00+81.8%+197.5%$309.08MN/A-2.89210ELVAElectrovaya2.7733 of 5 stars$6.14+0.8%$6.50+5.9%+178.7%$244.25M$44.62M204.7397Analyst ForecastNVXNOVONIX0.3379 of 5 stars$1.42+16.4%N/A-1.5%$203.00M$5.93M0.00N/AAnalyst ForecastGap UpHigh Trading VolumeNEOVNeoVolta1.3299 of 5 stars$4.55+0.9%$7.50+64.8%+95.0%$153.90M$4.26M-37.915News CoveragePositive NewsAnalyst ForecastGap UpSTEMStem1.0237 of 5 stars$17.20-3.7%$10.86-36.9%+182.5%$149.80M$144.58M-0.59660Analyst ForecastSKYXSKYX Platforms0.4475 of 5 stars$1.11-2.6%N/A+17.1%$127.05M$89.03M-3.0830Analyst ForecastGAUZGauzy2.8842 of 5 stars$5.98-2.8%$11.00+83.9%-20.0%$117.18M$103.53M-2.92N/APositive NewsAnalyst ForecastCBATChina BAK Battery1.0448 of 5 stars$0.90-0.4%N/A-15.2%$80.12M$176.62M-9.001,463News CoveragePositive NewsAnalyst ForecastGap Down Related Companies and Tools Related Companies Rice Acquisition Corp. II Competitors GrafTech International Competitors FREYR Battery Competitors Electrovaya Competitors NOVONIX Competitors NeoVolta Competitors Stem Competitors SKYX Platforms Competitors Gauzy Competitors China BAK Battery Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ULBI) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultralife Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultralife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
